GE healthcare BIO-sciences:1107247 [19-022214]
Ended Awarded
- Contract number
- 75N91019F00132
- Awardee
-
Global Life Sciences Solutions USA LLC UEI FG41DG32EGC3 Part of General Electric Company
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,440
Award facts
- Contract value 100% obligated
- $11,440.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Cancer Institute (NCI) to Global Life Sciences Solutions USA LLC, a subsidiary of Danaher Corporation headquartered in Marlborough, Massachusetts. The contract, valued at $11,440, was awarded on March 26, 2019, with an ultimate completion date of March 27, 2020, under firm fixed-price terms with no small business set-aside designation. The work will be performed in Bethesda, Maryland, the location of the National Institutes of Health (NIH) campus where NCI is situated. This BPA call falls under the broader $10 million single-award BPA that Global Life Sciences Solutions USA LLC maintains with the NIH Office of Logistics and Acquisition Operations through November 30, 2025.
Global Life Sciences Solutions USA LLC provides specialized scientific products and laboratory instrumentation to support biomedical research initiatives across multiple NIH institutes. Under this particular task order and the overarching BPA vehicle, the company supplies biological materials, media, chemicals, laboratory supplies, and advanced scientific equipment to support NCI's cancer research programs. The vendor's portfolio includes sophisticated chromatography systems, cell processing equipment, surface plasmon resonance instruments, and imaging systems, along with essential biological materials such as cell culture media and fetal bovine serum. This award reflects NCI's reliance on pre-negotiated BPA terms to efficiently procure critical laboratory materials and equipment necessary for ongoing cancer research operations.
Quick answers
Who was awarded contract 75N91019F00132?
75N91019F00132 was awarded to Global Life Sciences Solutions USA LLC by National Cancer Institute (National Institutes of Health) on March 26, 2019.
How much is contract 75N91019F00132 worth?
The government has obligated $11,440 on 75N91019F00132.
Is contract 75N91019F00132 an order under another contract?
Yes. 75N91019F00132 is a BPA call under HHSN263201600055B, a blanket purchase agreement.
Was contract 75N91019F00132 competed?
The extent of competition for 75N91019F00132 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award